par D'hoore, Leen;Germonpré, Peter;Rinia, Bert;Caeyers, Leonard;Stevens, Nancy;Balestra, Costantino 
Référence Diving and Hyperbaric Medicine, 55, 2, page (104-113)
Publication Publié, 2025-06-01

Référence Diving and Hyperbaric Medicine, 55, 2, page (104-113)
Publication Publié, 2025-06-01
Article révisé par les pairs
Résumé : | Long COVID syndrome is a major health issue. Multiple treatments have been proposed but efficacy is inadequately investigated. Hyperbaric oxygen therapy (HBOT) has been promoted based on a small number of publications. As there is potential for a placebo effect and the financial cost of HBOT is high, we sought to investigate the effects of HBOT in Long COVID in a randomised trial. |